Cargando…
Prognosis of stage III cervical cancer: a two-way outcome study
BACKGROUND: Cervical cancer is the second most common female malignancy worldwide, and the prognosis of patients with the locally advanced stage is poor, with a high risk of recurrent. This study aimed to explore the effect factors that influence the overall survival (OS), progression-free survival...
Autores principales: | Zhou, Huihui, Li, Qi, Xu, Chunyan, Liang, Hong, Wang, Yanan, Duan, Yani, Song, Min, Wang, Yaoxian, Jin, Hong, Wang, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798898/ https://www.ncbi.nlm.nih.gov/pubmed/35117616 http://dx.doi.org/10.21037/tcr.2020.02.70 |
Ejemplares similares
-
Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
por: Zhou, Huihui, et al.
Publicado: (2020) -
Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics
por: Zhou, Huihui, et al.
Publicado: (2019) -
Long-Term Survival Outcomes and Comparison of Different Treatment Modalities for Stage I-III Cervical Esophageal Carcinoma
por: Lu, Yanwei, et al.
Publicado: (2021) -
Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer
por: You, Weiqiang, et al.
Publicado: (2022) -
Validation of the 2018 FIGO Staging System for Predicting the
Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)